NeurosoftMIL:NRST 46 EBITDA Margin % is 14.37% as of Dec. 2025, which is 32% above its 10-year median of 10.88. GuruFocus rates MIL:NRST with a GF Score™ of 46/100 and a GF Value™ of €0.82 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 2,818 Software companies, Neurosoft ranks better than 58.73% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Neurosoft's EBITDA for the
six
months ended in Dec. 2025 was €2.69 Mil. Neurosoft's Revenue for the
six
months ended in Dec. 2025 was €18.72 Mil. Therefore, Neurosoft's EBITDA margin for the quarter that ended in Dec. 2025 was 14.37%.
Neurosoft (MIL:NRST) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Neurosoft EBITDA Margin % Related Terms
Neurosoft EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Neurosoft's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:NRST vs IBM, ACN, FISV: EBITDA Margin % Comparison
For the Information Technology Services subindustry, Neurosoft's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurosoft EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Neurosoft's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Neurosoft's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurosoft (MIL:NRST) has a EBITDA Margin % of 14.37% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Neurosoft and its competitors. This is 32% above median its historical median of 10.88. According to the industry distribution chart, Neurosoft ranks #1163 out of 2818 companies in the Software industry, placing it in the top 41.3%.
Is Neurosoft's EBITDA Margin % too high?
Neurosoft's current EBITDA Margin % of 14.37% is 32% above median its 10-year median of 10.88. The Software industry median EBITDA Margin % is 8.07. Neurosoft's value of 14.37% is 78.1% above this industry median. Based on the distribution chart, Neurosoft ranks #1163 out of 2818 companies in the Software industry, which is above the industry midpoint. Overall, Neurosoft has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurosoft's EBITDA Margin % compare to IBM and ACN?
According to the Software industry distribution chart, Neurosoft ranks #1163 out of 2818 companies for EBITDA Margin %. This puts Neurosoft in the upper half of its industry. The industry median EBITDA Margin % is 8.07. Neurosoft's value of 14.37% is 78.1% above this benchmark. While the company's 10-year median is 10.88 vs. the industry median of 8.07, Neurosoft has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.07, based on 2,818 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neurosoft's current EBITDA Margin % of 14.37% is 78.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Neurosoft and its competitors. For the Software industry, the median EBITDA Margin % is 8.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurosoft's current EBITDA Margin % is 14.37%, which is 32% above median its own 10-year median of 10.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurosoft stock overvalued right now?
Based on GuruFocus' analysis, Neurosoft (MIL:NRST) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.82, compared to a current price of €0.65 — trading 21.3% below its estimated fair value. The current EBITDA Margin % is 14.37%, which is 32% above median its 10-year median of 10.88 and 78.1% above the Software industry median of 8.07. Neurosoft's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Neurosoft (MIL:NRST), the current EBITDA Margin % is 14.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurosoft (MIL:NRST) Overvalued in 2026?
Based on GuruFocus' analysis, Neurosoft stock appears to be undervalued.
The current stock price of €0.65 is trading 21.3% below its estimated GF Value™ of €0.82.
GuruFocus considers Neurosoft to be Modestly Undervalued.
Key valuation signals for MIL:NRST:
EBITDA Margin %: 14.37% (32% above median its 10-year median of 10.88)
GF Value™: €0.82 vs. price of €0.65 (21.3% below fair value)
Industry Position: 78.1% above the Software median (#1163 of 2818)
No single metric tells the full story. See the MIL:NRST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurosoft SA is a software company. It designs, develops, customizes, and provides maintenance of integrated software systems for its business areas including Fintech and Analytics, System Engineering and Cyber Security Operations. The group operates under three business segments Cyber Security Operations, Field Services Operations and Infrastructure & Cloud Operations. The company generates majority of its revenue from the Field Services Operations segment.
46GF Score
Get the complete analysis for MIL:NRST
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:NRST has been successfully added to your 
